Immune checkpoint inhibitors induced autoimmune haemolytic anemia in patients with malignant cancer. (PubMed, Oncologist) - Oct 10, 2026 - "ICI-induced AIHA usually occurs early during ICI therapy and responds favorably to corticosteroid-based treatment. Pre-existing anemia in our cases should be regarded as a hypothesis-generating observation rather than evidence of a specific risk factor, underscoring the need for early hemolysis work-up and close monitoring when anemia worsens after ICI exposure."
Checkpoint inhibition • Journal • Anemia • Autoimmune Hemolytic Anemia • Hematological Disorders • Immunology • Lung Cancer • Melanoma • Non Small Cell Lung Cancer • Oncology • Solid Tumor
|
|
Aoxi Liang; Chunhong Hu; Fang Wu; Jisheng Li; Shengchi Chen; Shijiao Yao; Shuxing Wang; Xianling Liu; Yixing Luo; Yuanqiang Wu; Yue Pan; Yue Zeng
|